K.M. Tveit

701 total citations
16 papers, 580 citations indexed

About

K.M. Tveit is a scholar working on Oncology, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, K.M. Tveit has authored 16 papers receiving a total of 580 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Oncology, 5 papers in Surgery and 4 papers in Pulmonary and Respiratory Medicine. Recurrent topics in K.M. Tveit's work include Colorectal Cancer Treatments and Studies (6 papers), Cancer Treatment and Pharmacology (6 papers) and Colorectal Cancer Screening and Detection (4 papers). K.M. Tveit is often cited by papers focused on Colorectal Cancer Treatments and Studies (6 papers), Cancer Treatment and Pharmacology (6 papers) and Colorectal Cancer Screening and Detection (4 papers). K.M. Tveit collaborates with scholars based in Norway, Denmark and Sweden. K.M. Tveit's co-authors include Erik Carlsen, Arild Nesbakken, Helgi Sigurðsson, Ole Christian Lingjærde, Marianne G. Guren, Tormod Kyrre Guren, Arne Wibe, Morten Eriksen, Johan N. Wiig and Tone Ikdahl and has published in prestigious journals such as Journal of Clinical Oncology, British Journal of Cancer and Annals of Oncology.

In The Last Decade

K.M. Tveit

16 papers receiving 568 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
K.M. Tveit Norway 8 351 191 186 175 91 16 580
E. Dotor Spain 10 270 0.8× 173 0.9× 96 0.5× 154 0.9× 67 0.7× 23 462
Suebpong Tanasanvimon Thailand 10 285 0.8× 160 0.8× 257 1.4× 67 0.4× 70 0.8× 34 536
Shinichi Asaka Japan 12 161 0.5× 175 0.9× 109 0.6× 96 0.5× 99 1.1× 58 462
Michihiro Koizumi Japan 14 366 1.0× 153 0.8× 171 0.9× 234 1.3× 147 1.6× 52 604
Sanjun Cai China 14 345 1.0× 188 1.0× 115 0.6× 143 0.8× 109 1.2× 36 594
Andrea Grace Bocobo United States 8 389 1.1× 170 0.9× 506 2.7× 94 0.5× 136 1.5× 16 633
Yiping Du China 9 387 1.1× 259 1.4× 128 0.7× 346 2.0× 31 0.3× 13 703
Jacqui Adams United Kingdom 10 268 0.8× 289 1.5× 77 0.4× 146 0.8× 35 0.4× 21 555
Kristoffer Derwinger Sweden 16 430 1.2× 68 0.4× 231 1.2× 49 0.3× 137 1.5× 30 578
Ratislav Bahleda France 12 218 0.6× 168 0.9× 64 0.3× 114 0.7× 39 0.4× 31 458

Countries citing papers authored by K.M. Tveit

Since Specialization
Citations

This map shows the geographic impact of K.M. Tveit's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by K.M. Tveit with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites K.M. Tveit more than expected).

Fields of papers citing papers by K.M. Tveit

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by K.M. Tveit. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by K.M. Tveit. The network helps show where K.M. Tveit may publish in the future.

Co-authorship network of co-authors of K.M. Tveit

This figure shows the co-authorship network connecting the top 25 collaborators of K.M. Tveit. A scholar is included among the top collaborators of K.M. Tveit based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with K.M. Tveit. K.M. Tveit is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
2.
Li, Zhonghai, Hallgeir Rui, Erik S. Knudsen, et al.. (2012). Expression of cyclin D1a and D1b as predictive factors for treatment response in colorectal cancer. British Journal of Cancer. 107(10). 1684–1691. 21 indexed citations
3.
Byström, Per, et al.. (2012). Health-related quality of life in patients with metastatic colorectal cancer receiving palliative combination chemotherapy. 2 indexed citations
4.
Fluge, Øystein, Karsten Gravdal, Erik Carlsen, et al.. (2009). Expression of EZH2 and Ki-67 in colorectal cancer and associations with treatment response and prognosis. British Journal of Cancer. 101(8). 1282–1289. 123 indexed citations
5.
6.
Guren, Marianne G., Morten Eriksen, Johan N. Wiig, et al.. (2005). Quality of life and functional outcome following anterior or abdominoperineal resection for rectal cancer. European Journal of Surgical Oncology. 31(7). 735–742. 165 indexed citations
7.
Pfeiffer, Per, Bengt Glimelius, Halfdan Sørbye, et al.. (2004). Phase II study of short-time infusion of oxaliplatin in combination with capecitabine (XELOX30) in patients with progressive colorectal cancer after irinotecan and 5-fluorouracil (FU) treatment. Journal of Clinical Oncology. 22(14_suppl). 3562–3562. 1 indexed citations
8.
Pfeiffer, Per, Bengt Glimelius, Halfdan Sørbye, et al.. (2004). Phase II study of short-time infusion of oxaliplatin in combination with capecitabine (XELOX30) in patients with progressive colorectal cancer after irinotecan and 5-fluorouracil (FU) treatment. Journal of Clinical Oncology. 22(14_suppl). 3562–3562. 6 indexed citations
9.
Wibe, Arne, Astri Syse, Steinar Tretli, et al.. (2003). Long-term outcome following standardisation of rectal cancer surgery on a national level - the effects of quality control and hospital caseload. 1 indexed citations
10.
Glimelius, Bengt, et al.. (2003). 1066 Adjuvant chemotherapy in colorectal cancer: Joint analyses of randomised trials by the Nordic Gastrointestinal Tumour Adjuvant Therapy Group. European Journal of Cancer Supplements. 1(5). S318–S319. 6 indexed citations
11.
Dahl, O., K.M. Tveit, Esben Andreas Carlsen, et al.. (2003). 1084 Only colon cancer patients with Dukes stage C benefit from adjuvant chemotherapy with 5-fluorouracil and levamisole among 425 patients with operable colorectal cancer in a Norwegian randomised study. European Journal of Cancer Supplements. 1(5). S324–S324. 1 indexed citations
12.
Glimelius, Bengt, Å. Berglund, Tone Fokstuen, et al.. (2003). 290 Nordic 5-fluorouracil/folinic acid bolus schedule combined with oxaliplatin (FLOX) as first-line treatment to metastatic colorectal cancer. European Journal of Cancer Supplements. 1(5). S89–S89. 2 indexed citations
13.
Bretthauer, Michael, Ghous Gondal, Esben Andreas Carlsen, et al.. (2002). Design, Organization and Management of a Controlled Population Screening Study for Detection of Colorectal Neoplasia: Attendance Rates in the NORCCAP Study (Norwegian Colorectal Cancer Prevention). Scandinavian Journal of Gastroenterology. 37(5). 568–573. 69 indexed citations
14.
Geisler, Jürgen, et al.. (1998). Microencapsulated octreotide pamoate in advanced gastrointestinal and pancreatic cancer: a phase I study. British Journal of Cancer. 78(1). 14–20. 12 indexed citations
15.
Geisler, Jürgen, Stefanie Geisler, Per Eystein Lønning, et al.. (1998). Changes in folate status as determined by reduction in total plasma homocysteine levels during leucovorin modulation of 5-fluorouracil therapy in cancer patients.. PubMed. 4(9). 2125–8. 12 indexed citations
16.
Ottestad, Lars, K.M. Tveit, Sigmund Vaage, et al.. (1988). Cultivation of human breast carcinoma in soft agar. Experience with 237 fresh tumour specimens. British Journal of Cancer. 58(1). 8–12. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by E. Dotor Breakdown of academic impact, for papers by Suebpong Tanasanvimon Breakdown of academic impact, for papers by Shinichi Asaka Breakdown of academic impact, for papers by Michihiro Koizumi Breakdown of academic impact, for papers by Sanjun Cai Breakdown of academic impact, for papers by Andrea Grace Bocobo Breakdown of academic impact, for papers by Yiping Du Breakdown of academic impact, for papers by Jacqui Adams Breakdown of academic impact, for papers by Kristoffer Derwinger Breakdown of academic impact, for papers by Ratislav Bahleda
Rankless by CCL
2026